Convertible Note - Evox Therapeutics
Investment Firm
Overview
Evox Therapeutics is a biotechnology company that harnesses and engineer the natural trafficking capabilities of extracellular vesicles.
Announced Date
Jun 09, 2020
Funding Type
Convertible Note
Highlights
Location
Europe
Social
Participant Investors
1
| Investor Name |
|---|
Round Details and Background
Evox Therapeutics raised $10000000 on 2020-06-09 in Convertible Note
Evox Therapeutics is a biotechnology company that harnesses and engineer the natural trafficking capabilities of extracellular vesicles.
Company Funding History
6
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Mar 22, 2019 |  Grant - Evox Therapeutics | 1 | - | 2.0M |
| Feb 18, 2021 | Series C - Evox Therapeutics | 7 | - | 96.7M |
| Jun 09, 2020 | Convertible Note - Evox Therapeutics | 1 | - | 10.0M |
| May 11, 2016 | Series A - Evox Therapeutics | 1 | - | 14.4M |
Recent Activity
There is no recent news or activity for this profile.